09-25-2018 09:44 AM CET - Health & Medicine

Regenerative Medicine Market 2018-2025 With Global Product Type Analysis, Substitute Study and Dominating Players Like Integra LifeSciences, MiMedx, AstraZeneca, Roche, Merck, Pfizer, Baxter International Inc., NuVasive, Osiris Therapeutics

Press release from: Data Bridge Market Research
Regenerative Medicine Market
Regenerative Medicine Market
Databridgemarketresearch.com adds “Regenerative Medicine Market 2018-2025 With Global Product Type Analysis, Substitute Study and Dominating Players Like Integra LifeSciences, MiMedx, AstraZeneca, Roche, Merck, Pfizer, Baxter International Inc., NuVasive, Organogenesis Inc., Osiris Therapeutics, Vericel, Stryker” reports to its database.

This report provides in depth study of “Regenerative Medicine Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Regenerative Medicine Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report focuses on the Regenerative Medicine Market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Global Regenerative Medicine Market development in South America, North America, Europe, Middle East & Africa, Asia-Pacific.

Download PDF Sample Copy of Report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Major Market Drivers and Restraints:

• Increase in prevalence of chronic diseases.
• emergence of stem cell technology
• for research on untapped potential of nanotechnology
• rise in incidence of degenerative diseases
• High cost for advancement in the technology.
• Lack of operational efficiency.

Market Analysis: Global Regenerative Medicine Market

The Global Regenerative Medicine Market is expected to reach USD 57730.89 million by 2025, from USD 7077.2 million in 2017 growing at a CAGR of 30.0% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Regenerative medicine presents with opportunities to change the treatment options and offers complete cure for the diseases. Regenerative medicines are useful for various purposes like replace, repair, regenerate tissues and organs gets affected due to disease, natural aging process or injury. There are number of companies that are indulging in the research and development of such therapies now. For instance, according to published article, in 2014, regenerative medicine reports 4749 registries of clinical trials related to stem cell treatment. In recognition of the integral role of the Food and Drug Administration (FDA) in the successful development of this field, NIH is leading the RMIP in coordination with FDA. According to the Centers for Disease Control and Prevention (CDC), over 117 million individuals in the US were suffering from one or more than that chronic health conditions in 2012. In 2016, it was found that there was an increase in the prevalence of acute wounds such as surgical and traumatic wounds across the globe and also observed that surgical wounds in global prevalence was 135,000.

Market Segmentation: Global Regenerative Medicine Market

Based on product type:

• Therapy
• Material
• Application
• Geographical Segments

Based on product type:

• Cell Based
• Acellular

On the basis of therapy:

• Tissue Engineering
• Immunotherapy
• Cell Therapy
• Gene Therapy

On the basis of material:

• Synthetic Material
• Pharmaceutical
• Genetically Engineered Material
• Biologically Derived Material

On the basis of application:

• Dermatology
• Orthopedic & Musculoskeletal Disorders
• Cardiology Oncology

Based on geography:

• North America
• South America
• Europe
• Asia-Pacific
• Middle East & Africa

Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

To Avail 10% Discount On This Report Mail Us on: - sopan.gedam@databridgemarketresearch.com

Key Developments in the Market:

In December 2016, the Regenerative Medicine Innovation Project (RMIP) established to accelerate the field by supporting clinical research on adult stem cells along with promoting the highest standards for carrying out scientific research and protecting patient safety.

In April 2018, The Food and Drug Administration (FDA) have programs considered to expedite the drug development and review processes for promising pipeline products. These programs include accelerated approval, fast track, breakthrough and priority review designations. The newest of these programs is Regenerative Medicine Advanced Therapy (RMAT).

Competitive Analysis: Global Regenerative Medicine Market

The global regenerative medicine market is highly fragmented and the major players have used various strategies such as number of therapies, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of regenerative medicine market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors/Players: Global Regenerative Medicine Market

Some of the major players operating in the global regenerative medicine market are –

• Integra LifeSciences Corporation,
• MiMedx Group, Inc,
• AstraZeneca,
• F. Hoffmann-La Roche Ltd,
• Merck & Co., Inc.,
• Pfizer Inc.,
• Baxter,
• Nuvasive, Inc,
• Organogenesis Inc.,
• Osiris Therapeutics, Inc. (U.S.),
• Vericel Corporation,
• Stryker Corporation,
• Medtronic (Ireland),
• Acelity (KCI Concepts) (U.S.),
• Cook Biotech Inc.,
• C.R. Bard (U.S.),
• Vericel Corporation,
• U.S. Stem Cell,
• Athersys, Inc.,
• CryoLife, Inc.,
• Medtronic Plc.,
• Among others

Reasons to Purchase this Report

• Current and future of Global Regenerative Medicine Market outlook in the developed and emerging markets

• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

• Regions/countries that are expected to witness the fastest growth rates during the forecast period

• The latest developments, market shares, and strategies that are employed by the major market players

Order a Copy of Global Regenerative Medicine Market 2018 Report @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1260092 • Views: 746
More releasesMore releases

You can edit or delete your press release here: